Nevirapine pharmacokinetics when initiated at 200 mg or 400 mg daily in HIV-1 and tuberculosis co-infected Ugandan adults on rifampicin

M Lamorde, P Byakika-Kibwika, V Okaba-Kayom, M Ryan, P Coakley, M Boffito, R Namakula, F Kalemeera, R Colebunders, D Back, S Khoo, C Merry

    Research output: Contribution to journal › A1: Web of Science-article

    Fingerprint Dive into the research topics of 'Nevirapine pharmacokinetics when initiated at 200 mg or 400 mg daily in HIV-1 and tuberculosis co-infected Ugandan adults on rifampicin'. Together they form a unique fingerprint.

    Medicine & Life Sciences